A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV trials network protocol 080.

Montaner, J S; Zala, C; Conway, B; Raboud, J; Patenaude, P; Rae, S; O'Shaughnessy, M V; Schechter, M T

Montaner, J S; Zala, C; Conway, B; Raboud, J; Patenaude, P; Rae, S; O'Shaughnessy, M V; Schechter, M T.

Affiliation

Montaner JS; Department of Medicine, University of British Columbia, Vancouver, Canada.

J Infect Dis ; 175(4): 801-6, 1997 Apr.

Article in En | MEDLINE | ID: mdl-9086133

Subject(s)

Antiviral Agents/therapeutic use; Didanosine/therapeutic use; HIV Infections/drug therapy; Hydroxyurea/therapeutic use; Adult; CD4 Lymphocyte Count; Female; Humans; Hydroxyurea/adverse effects; Male; Middle Aged; Pilot Projects; RNA, Viral/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / HIV Infections / Didanosine / Hydroxyurea Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 1997 Document type: Article Affiliation country: Canada Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links